Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

LAB Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 25, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Standard BioTools Inc (LAB)

Based on 7 analysts giving stock ratings to Standard BioTools Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
29
Hold
42
Sell
0
Strong Sell
0
Standard BioTools Inc

Standard BioTools Inc. Stock Analysis LAB

United States Health Care Small Cap Report:
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. The company is headquartered in Boston, Massachusetts and currently employs 385 full-time employees. The company went IPO on 2011-02-10. The firm develops, manufactures and sells a diversified range of instrumentation, consumables, and services. The firm's Genomics business includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. Its Biomark X9 system for high-throughput genomics delivers scalability for qPCR applications. Designed for researchers who require robust multiplexing capabilities, the Biomark X9 system enables the simultaneous analysis of thousands of reactions in a single run. By leveraging advanced microfluidics technology, it reduces reagent consumption while increasing throughput, making it a solution for large-scale genomic studies, clinical research, and biomarker discovery. The Biomark X9 system integrates with data analysis tools, accelerating workflows and providing comprehensive insights.
Read More

Standard BioTools Inc (LAB) Chart

Key Statistics of Standard BioTools Inc (LAB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.78$0.83

Today's Open

$0.78

Volume

4.71M

P/E Ratio (TTM)

-

52 Week Range

$0.76$1.72

Market Cap

405.98M

Avg. Volume

4.08M

Dividend Yield

-

Financial Metrics & Statements of Standard BioTools Inc (LAB)

FAQ's for Standard BioTools Inc (LAB)

  • According to Musaffa’s Shariah screening methodology, Standard BioTools Inc (LAB) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Standard BioTools Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Standard BioTools Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Standard BioTools Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Standard BioTools Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Standard BioTools Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.